Skip to main content
logo
Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
19.10
+0.34 (1.81%)
At close: Jul 29, 2026, 4:00 PM EDT
19.40
+0.30 (1.57%)
After-hours: Jul 29, 2026, 7:34 PM EDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Affordable Medicines Net Revenue
1.75B1.75B1.69B
Specialty Net Revenue
553.48M528.51M445.75M
AvKARE Net Revenue
738.33M744.73M662.95M
Revenue (Total)
3.05B3.02B2.79B

Gross Profit

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Affordable Medicines Gross Profit
702.64M683.92M673.90M
Specialty Gross Profit
317.62M282.59M242.93M
AvKARE Gross Profit
157.26M146.79M103.61M
Gross Profit (Total)
1.18B1.11B1.02B

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Affordable Medicines Operating Income
390.95M380.80M270.10M
Specialty Operating Income
151.07M116.00M113.58M
AvKARE Operating Income
93.10M83.62M42.90M
Corporate and Other Operating Income
-199.60M-186.32M-177.26M
Operating Income (Total)
435.52M394.10M249.33M